Evidence Hub

Diagnosis of Chlamydia psittaci pneumonia using targeted next-generation sequencing: case report and clinical characteristics statistics

Yu M, Wang W, Zhou H, Kumar A, Zhao X, Qian F, Zhong X, Nie C et al.

Frontiers in medicine, 2025

Abstract

Chlamydia psittaci (Cps) is a Gram-negative intracellular bacterium with birds as its main host. Humans are mainly infected through contact with birds and poultry. The main route is through inhalation of aerosols contaminated by animal excrement through the respiratory tract. The main manifestation after infection is pneumonia, and in severe cases, it can lead to multiple organ failure. Targeted Next-generation Sequencing (tNGS) can detect rare pathogens that are difficult to detect with traditional detection methods, which has continuously improved the detection rate of Cps. This article reports 12 cases of psittacosis pneumonia diagnosed by tNGS of bronchoalveolar lavage fluid (BALF) obtained by bronchoscopy or sputum. The cases are improved after regular treatment, and the clinical characteristics are analyzed at the same time.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free